Replacing Needle Injection by a Novel Waterjet Technology Grants Improved Muscle Cell Delivery in Target Tissues

Author:

Geng Ruizhi1ORCID,Knoll Jasmin1,Harland Niklas2ORCID,Amend Bastian2,Enderle Markus D.3,Linzenbold Walter3,Abruzzese Tanja1,Kalbe Claudia4,Kemter Elisabeth56,Wolf Eckhard56,Schenk Martin7,Stenzl Arnulf2,Aicher Wilhelm K.1ORCID

Affiliation:

1. Department of Urology, Center for Medical Research, Eberhard Karl University of Tübingen, Tübingen, Germany

2. Department of Urology, University of Tübingen Hospital, Eberhard Karl University of Tübingen, Tübingen, Germany

3. Erbe Elektromedizin GmbH, Tübingen, Germany

4. Institute of Muscle Biology and Growth, Research Institute for Farm Animal Biology, Dummerstorf, Germany

5. Department of Molecular Animal Breeding and Biotechnology, LMU Munich, Oberschleißheim, Germany

6. Center for Innovative Medical Models, LMU Munich, Oberschleißheim, Germany

7. Department of Surgery, University of Tübingen Hospital, Eberhard Karl University of Tübingen, Tübingen, Germany

Abstract

Current regimen to treat patients suffering from stress urinary incontinence often seems not to yield satisfactory improvement or may come with severe side effects. To overcome these hurdles, preclinical studies and clinical feasibility studies explored the potential of cell therapies successfully and raised high hopes for better outcome. However, other studies were rather disappointing. We therefore developed a novel cell injection technology to deliver viable cells in the urethral sphincter complex by waterjet instead of using injection needles. We hypothesized that the risk of tissue injury and loss of cells could be reduced by a needle-free injection technology. Muscle-derived cells were obtained from young male piglets and characterized. Upon expansion and fluorescent labeling, cells were injected into cadaveric tissue samples by either waterjet or injection needle. In other experiments, labeled cells were injected by waterjet in the urethra of living pigs and incubated for up to 7 days of follow-up. The analyses documented that the cells injected by waterjet in vitro were viable and proliferated well. Upon injection in live animals, cells appeared undamaged, showed defined cellular somata with distinct nuclei, and contained intact chromosomal DNA. Most importantly, by in vivo waterjet injections, a significantly wider cell distribution was observed when compared with needle injections ( P < .05, n ≥ 12 samples). The success rates of waterjet cell application in living animals were significantly higher (≥95%, n = 24) when compared with needle injections, and the injection depth of cells in the urethra could be adapted to the need by adjusting waterjet pressures. We conclude that the novel waterjet technology injects viable muscle cells in tissues at distinct and predetermined depth depending on the injection pressure employed. After waterjet injection, loss of cells by full penetration or injury of the tissue targeted was reduced significantly in comparison with our previous studies employing needle injections.

Funder

EU

Bundesministerium für Bildung und Forschung

Deutsche Forschungsgemeinschaft

BMBF

Zukunftsfonds, FBN Dummerstorf

Publisher

SAGE Publications

Subject

Transplantation,Cell Biology,Biomedical Engineering

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3